Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis

The validity of register data to identify children with atopic dermatitis, asthma or allergic... INTRODUCTIONThe rates of atopic eczema, wheezing, asthma and allergic rhinoconjunctivitis, which have been increasing in high‐income countries, appear to be stabilizing at a level of 20%‐40% of the population being affected; however, the rates may still be increasing in low‐income countries. Large local variabilities in the prevalence of atopic diseases have been documented globally in the most recent report from The International Study of Asthma and Allergies in Childhood. The causes of the variability and changes remain unclear; both genetics and environment have been found to be influential.As medicine increases its need to manage populations of individuals with specific diseases to improve care and prevention at the lowest cost, large‐scale epidemiological studies using register‐based identification of subpopulations become increasingly valuable. Such studies can identify risk factors, and follow‐up on disease rates and interventions.In a recent study, we developed methods, that is algorithms to identify children at a population level with atopic dermatitis, asthma or allergic rhinoconjunctivitis using data from public national health registers in Denmark and Sweden. These algorithms used information on disease‐specific dispensed prescribed medication and hospital contacts, and a criterion of repeated use of disease‐specific medication within 12 months was used to secure the specificity. However, sensitivity and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pediatric Allergy and Immunology Wiley

The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis

Loading next page...
 
/lp/wiley/the-validity-of-register-data-to-identify-children-with-atopic-RUozw05aFc

References (24)

Publisher
Wiley
Copyright
Copyright © 2017 John Wiley & Sons A/S
ISSN
0905-6157
eISSN
1399-3038
DOI
10.1111/pai.12743
pmid
28632331
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONThe rates of atopic eczema, wheezing, asthma and allergic rhinoconjunctivitis, which have been increasing in high‐income countries, appear to be stabilizing at a level of 20%‐40% of the population being affected; however, the rates may still be increasing in low‐income countries. Large local variabilities in the prevalence of atopic diseases have been documented globally in the most recent report from The International Study of Asthma and Allergies in Childhood. The causes of the variability and changes remain unclear; both genetics and environment have been found to be influential.As medicine increases its need to manage populations of individuals with specific diseases to improve care and prevention at the lowest cost, large‐scale epidemiological studies using register‐based identification of subpopulations become increasingly valuable. Such studies can identify risk factors, and follow‐up on disease rates and interventions.In a recent study, we developed methods, that is algorithms to identify children at a population level with atopic dermatitis, asthma or allergic rhinoconjunctivitis using data from public national health registers in Denmark and Sweden. These algorithms used information on disease‐specific dispensed prescribed medication and hospital contacts, and a criterion of repeated use of disease‐specific medication within 12 months was used to secure the specificity. However, sensitivity and

Journal

Pediatric Allergy and ImmunologyWiley

Published: Sep 1, 2017

Keywords: ; ; ; ; ; ; ; ; ; ;

There are no references for this article.